Calcium and phosphate metabolism management in chronic renal disease /

Saved in:
Bibliographic Details
Imprint:New York, NY : Springer, c2006.
Description:1 online resource (xii, 185 p.) : ill.
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8881976
Hidden Bibliographic Details
Other authors / contributors:Hsu, Chen Hsing, 1938-
ISBN:9780387333700
0387333703
6610803560 (electronic bk.)
9786610803569 (electronic bk.)
9780387333694 (alk. paper)
038733369X (alk. paper)
Notes:Includes bibliographical references and index.
Description based on print version record.
Other form:Print version: Calcium and phosphate metabolism management in chronic renal disease. New York, NY : Springer, c2006 9780387333694 038733369X
Table of Contents:
  • Cover
  • Contents
  • Contributors
  • Preface
  • Chapter 1: Historical Perspective of Calcium Management in Patients with Chronic Renal Diseases
  • I. Introduction
  • II. Calcium Metabolism in Normal Subjects
  • III. Calcium Metabolism in Patients with CRD
  • A. Calcium Absorption in CRD Patients
  • B. Management of Calcium in Renal Dialysis Patients
  • C. Urinary Excretion of Calcium in CRD
  • D. Calcium Metabolic Problems in Renal Transplant Patients
  • E. Management of Calcium Metabolism in CRD Patients
  • F. Conclusion
  • Chapter 2: Disorders of Phosphorous Homeostasis in CKD
  • I. Introduction
  • II. Normal Phosphorus Homeostasis
  • III. Intestinal Absorption
  • IV. Renal Handling
  • V. Bone Remodeling
  • VI. Phosphatonins
  • VII. Disorders of P<sub>i</sub> in Non-CKD Patients
  • A. Hypophosphatemia
  • B. Hyperphosphatemia
  • VIII. Disorders of P<sub>i</sub> In CKD Patients
  • IX. Dialytic Removal of Phosphate
  • X. Consequences of Hyperphosphatemia
  • XI. Conclusions
  • Chapter 3: Pathogenesis and Management of Secondary Hyperparathyroidism
  • I. Introduction
  • II. Pathogenesis
  • A. Role of Phosphate
  • B. Phosphotonins
  • III. Clinical Manifestations
  • A. Bone Disease
  • B. Calciphylaxis
  • C. Vascular Calcification
  • IV. Management of Secondary Hyperparathyroidism
  • A. Phosphorus Control
  • B. Dietary Phosphorus Restriction
  • C. Phosphorus Binders
  • D. Vitamin D Therapy
  • E. Calcimimetics
  • F. Parathryoidectomy
  • V. Conclusion
  • Chapter 4: Uremic Toxins in Chronic Renal Failure
  • I. Introduction
  • II. Uremic Solute Retention
  • A. General Classification of Uremic Solutes
  • B. Main Uremic Retention Products
  • III. Conclusion
  • Chapter 5: Calcitriol Metabolism and Action in Chronic Renal Disease
  • I. Introduction
  • II. Effect of Calcitriol on Various Organs
  • A. Effect of Calcitriol on the Nervous System
  • B. Effect of Calcitriol on Cardiac Function
  • C. Effect of Calcitriol on the Parathyroid Gland
  • D. Effect of Calcitriol on Colon Carcinogenesis
  • E. Effect of Calcitriol on Prostate Cancer
  • F. Effect of Calcitriol on Pulmonary Cancer
  • G. Immunoregulatory Function of Calcitriol
  • III. Calcitriol Production in Chronic Renal Disease
  • A. Decreased Renal Tissue
  • B. Hyperphosphatemia
  • C. Metabolic Acidosis
  • D. Extrarenal Production of Calcitriol
  • E. Uremic Toxins
  • F. Purine Derivatives
  • G. Parathyroid Hormone (PTH)
  • H. Effect of Glucose on the Function of the Calcitriol Receptor and Vitamin D Metabolism
  • IV. Metabolic Degradation of Calcitriol in Renal Failure
  • V. Reduced Calcitriol Receptor Concentration in Chronic Renal Disease
  • VI. Hormone-Receptor Interaction with Nuclear Chromatin Is Decreased in Chronic Renal Failure
  • VII. Secondary Hyperparathyroidism and Calcitriol
  • VIII. Effect of Uremia on Other Members of the Steroid Hormone Receptor Superfamily
  • IX. Conclusion
  • Chapter 6: Renal Osteodystrophy
  • I. Introduction
  • II. Classification of Bone Disease
  • III. Clinical Manifestations
  • IV. O.